Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag to Enhance Platelet Count Recovery in Elderly Patients With Acute Myeloid Leukemia Undergoing Remission Induction Therapy
NCT02071901Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Aug 2014
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in acute myeloid leukemia (AML), sponsored by Case Comprehensive Cancer Center. Started Aug 2014; status: completed.
02
Drugs
eltrombopag
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02071901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071901.